indicated that anti-SORT1 could inhibit SORT1 to increase the level of PGRN in the cerebrospinal fluid, which is beneficial to the prognosis of frontotemporal dementia (FTD) (49). This evidence concerns the gene SORT1 and frontotemporal dementia.